Please use this identifier to cite or link to this item:
|Title:||Degradation of angiotensin I to [des-Asp1]angiotensin I by a novel aminopeptidase in the rat hypothalamus|
|Authors:||Sim, M.K. |
|Citation:||Sim, M.K., Choo, M.H.H., Qiu, X.S. (1994). Degradation of angiotensin I to [des-Asp1]angiotensin I by a novel aminopeptidase in the rat hypothalamus. Biochemical Pharmacology 48 (5) : 1043-1046. ScholarBank@NUS Repository. https://doi.org/10.1016/0006-2952(94)90376-X|
|Abstract:||The particulate enzyme that degrades angiotensin I (ANG I) to [des-aspartate1]angiotensin I ([des-Asp1]ANG I) in the hypothalamic homogenate of the rat has been established as a specific aminopeptidase. The major characteristic is its resistance to inhibition by 10-4 M amastatin, bestatin and EDTA. Among the four amino acyl-β-naphthylamides (aspartyl-, glutamyl-, arginyl- and leucyl-β-naphthylamide), aspartyl-β-naphthylamide is the most susceptible substrate of the enzyme; being degraded at twice the rate of arginyl- and leucyl-β-naphthylamide, and six times that of glutamyl-β-naphthylamide. Although the precise role of this aminopeptidase has yet to be determined, its presence establishes the existence of a specific pathway for the degradation of ANG I that bypasses the formation of ANG II. The relationship between degradation and hypertension is shown by our recent findings that the formation of [des-Asp1]ANG I form ANG I in the hypothalamic homogenate of the spontaneously hypertensive rat (SHR) is significantly enhanced, and the findings of other investigators that the production of ANG II by neuronal cultures of the SHR is significantly decreased.|
|Source Title:||Biochemical Pharmacology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on May 19, 2018
WEB OF SCIENCETM
checked on Apr 2, 2018
checked on May 5, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.